Manganese hydrogen phosphate
Drug ingredientCAS 51349-94-1
manganese phosphate, dibasic
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
5 FDA-registered drug labelers
Deseret Biologicals, Inc.
Guna spa
Hahnemann Laboratories, INC.
Nucleic Products, LLC
OHM PHARMA INC.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 8 drug and cosmetic product listings (FDA).
- •Manganum Phosphoricum
- •Bio Cytotox Phase
- •Bio Co-Enzyme Phase
- •GUNA-CELL
- •Omeosport
- •Male Stimulant
- •Apnetem
- •OHM-DREN LFT
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS51349-94-1
PubChem CID6452420
DTXSIDDTXSID40872546
FormulaHMnO4P
Mol. Weight150.917 g/mol
SMILESOP(=O)([O-])[O-].[Mn+2]
Data Sources
- PubChem · compound 6452420Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Manganese hydrogen phosphate (CAS 51349-94-1) https://chemicalindependence.com/chemical/51349-94-1/ PubChem: 6452420. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/6452420 FDA National Drug Code directory: CAS 51349-94-1. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/